Key result
ITA grafts cut long-term graft failure ~67% compared to saphenous vein grafts in Kawasaki disease.
Why the study?
Coronary artery bypass grafting is performed in Kawasaki disease with coronary inflammation and aneurysms, and this study aimed to determine which surgical strategy provides superior graft patency and early and long-term outcomes.
Does surgical myocardial revascularization using internal thoracic arteries or other arterial conduits improve long-term graft patency and survival compared to saphenous vein grafts in patients with Kawasaki disease?
Meta-Analysis (n=1,191)
Does surgical myocardial revascularization using internal thoracic arteries or other arterial conduits improve long-term graft patency and survival compared to saphenous vein grafts in patients with Kawasaki disease?
In pediatric and young patients undergoing CABG for Kawasaki disease coronary complications, arterial grafting—particularly with internal thoracic arteries—is safe and yields significantly better long-term graft patency and survival than venous grafting.
Answers are grounded in this paper and cite their sources.
Supports ITA preference over SVG for CABG in Kawasaki disease; extends adult CAD evidence to this pediatric population.
Background Kawasaki disease (KD) is a systemic inflammatory condition occurring predominantly in children. Coronary artery bypass grafting (CABG) is performed in the presence of inflammation and aneurysms of the coronary arteries. The objectives of our study were to assess which CABG strategy provides better graft patency and early and long-term outcomes. Methods A systematic review using Medline, Cochrane, and Scopus databases was performed in February 2020, incorporating a network meta-analysis, performed by random-effect model within a Bayesian framework, and pooled prevalence of adverse outcomes. Hazard ratios (HR) and corresponding 95% credible intervals (CI) were calculated by Markov chain Monte Carlo methods. Results Among 581 published reports, 32 studies were selected, including 1,191 patients undergoing CABG for KD. Graft patency of internal thoracic arteries (ITAs), saphenous veins (SV), and other arteries (gastroepiploic artery and radial artery) was compared. ITAs demonstrated the best patency rates at long-term follow-up (HR 0.33, 95% CI: 0.17–0.66). Pooled prevalence of early mortality after CABG was 0.28% (95% CI: 0.00–0.73%, I 2 = 0%, tau2 = 0), with 63/1,108 and 56/1,108 patients, undergoing interventional procedures and surgical re-interventions during follow-up, respectively. Pooled prevalence was 3.97% (95% CI: 1.91–6.02%, I 2 = 60%, tau2 = 0.0008) for interventional procedures and 3.47% (95% CI: 2.26–4.68%, I 2 = 5%, tau2 <0.0001) for surgical re-interventions. Patients treated with arterial, venous, and mixed (arterial plus second venous graft) CABG were compared to assess long-term mortality. Mixed CABG (HR 0.03, 95% CI: 0.00–0.30) and arterial CABG (HR 0.13, 95% CI: 0.00–1.78) showed reduced long-term mortality compared with venous CABG. Conclusions CABG in KD is a safe procedure. The use of arterial conduits provides better patency rates and lower mortality at long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Salsano et al. (2021) conducted a meta-analysis in Kawasaki disease undergoing coronary artery bypass grafting (n=1,191). Internal thoracic artery (ITA) and other arterial (gastroepiploic and radial artery) CABG conduits vs. Saphenous vein (SV) CABG conduits was evaluated on Long-term graft patency (defined as absence of >70% coronary stenosis or occlusion on invasive or CT angiography) (HR 0.33, 95% CI 0.17–0.66). Internal thoracic artery grafts demonstrated superior long-term patency compared to saphenous vein grafts in patients undergoing CABG for Kawasaki disease.
Synapse has enriched 10 related papers. Consider them for comparative context: